Antiandrogen Monotherapy: Recommendations for the Treatment of Prostate Cancer

@article{Sciarra2004AntiandrogenMR,
  title={Antiandrogen Monotherapy: Recommendations for the Treatment of Prostate Cancer},
  author={A. Sciarra and A. Cardi and F. di Silverio},
  journal={Urologia Internationalis},
  year={2004},
  volume={72},
  pages={91 - 98}
}
  • A. Sciarra, A. Cardi, F. di Silverio
  • Published 2004
  • Medicine
  • Urologia Internationalis
  • Objective: The concept of antiandrogens as monotherapy for the treatment of prostate cancer is discussed. Methods: Both Medline and Current Contents were used to identify studies on antiandrogen monotherapy in prostate cancer. We tried to analyze this database critically to estabilish whether or not there is evidence for using this monotherapy. Results: In particular, bicalutamide in monotherapy has been compared with castration in large international trials. Results show that antiandrogen… CONTINUE READING
    15 Citations

    Topics from this paper.

    Overview of the latest treatments for castration-resistant prostate cancer
    • 47
    • PDF
    Current management of castrate-resistant prostate cancer.
    • 156
    • PDF
    Safety and tolerability of intermittent androgen deprivation therapy: A literature review
    • D. Gruca, P. Bacher, U. Tunn
    • Medicine
    • International journal of urology : official journal of the Japanese Urological Association
    • 2012
    • 22

    References

    SHOWING 1-10 OF 47 REFERENCES
    Quality of Life Issues Relating to Endocrine Treatment Options
    • 50
    Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer patients: results of an Italian Prostate Cancer Project study.
    • 136